Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Longeveron Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +4 vs. Q2 2022
- Shares held
- 444.0K
- +65.8K (+17.4%) vs. Q2 2022
- Total value
- $1.64M
- −$600.4K (−26.8%) vs. Q2 2022
- New holders
- 6
- 4 more added
- Sold out
- 2
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 184,267 | $682.0K | 0.00% | +10,600+6.1% | Added |
| BlackRock Inc. | 109,729 | $406.0K | 0.00% | −270−0.2% | Reduced |
| Geode Capital Management, LLC | 35,718 | $132.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 27,347 | $101.0K | 0.00% | +27,347 | New |
| State Street Corp | 14,800 | $55.0K | 0.00% | 00.0% | Unchanged |
| TownSquare Capital, LLC | 14,450 | $53.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 12,900 | $48.0K | 0.00% | −1,200−8.5% | Reduced |
| XTX Topco Ltd | 10,683 | $40.0K | 0.01% | +10,683 | New |
| Northern Trust Corp | 10,623 | $39.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 10,356 | $38.0K | 0.00% | +10,356 | New |
| Morgan Stanley | 8,679 | $32.0K | 0.00% | +7,379+567.6% | Added |
| Advisor Group Holdings, Inc. | 2,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,418 | $5.00K | 0.00% | +787+124.7% | Added |
| BNP Paribas Arbitrage, SA | 700 | $2.59K | 0.00% | +700 | New |
| The PNC Financial Services Group, Inc. | 220 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 36 | $0 | 0.00% | +4+12.5% | Added |
| FMR LLC | 10 | $0 | 0.00% | +10 | New |
| Royal Bank of Canada | 54 | $0 | 0.00% | +54 | New |
| UBS Group AG | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −105−100.0% | Sold out |